During mouse cytomegalovirus (MCMV) infection, the first wave of type I interferon (IFN-I) production peaks at ϳ8 h. This IFN-I emanates from splenic stromal cells located in the marginal zone (MZ) and requires B cells that express lymphotoxin. The amount of IFN-I produced at these initial times is at least equivalent in magnitude to that produced later by dendritic cells (ϳ36 to 48 h), but the relative roles of these two IFN-I sources in regulating MCMV defense remain unclear. Here we show that IFN-I produced by MZ stromal cells dramatically restricts the first measurable burst of viral production, which occurs at ϳ32 h. This primary innate control by IFN-I is partially mediated through the activation of natural killer (NK) cells, which produce gamma interferon in an IFN-I-dependent fashion, and is independent of Ly49H. Strikingly, MCMV production in the spleens of immunocompetent mice never increases at times after 32 h. These results highlight the critical importance of lymphoid-tissue stromal cells in orchestrating the earliest phase of innate defense to MCMV infection, capping replication levels, and blocking spread until infection is ultimately controlled.
C
ytomegalovirus (CMV; a betaherpesvirus) infects the majority of the world's population (1) . Primary CMV infection is usually asymptomatic in healthy individuals; however, in persons with suppressed or underdeveloped immunity, it can result in serious disease (2) . Upon immune suppression, CMV reactivates rapidly from latency, demonstrating the need for constant immune surveillance to maintain homeostasis between CMV and its host over this lifetime infection. The complexity of this intricate relationship between CMV and its host makes it ideal for use in case studies of how host immunity controls the various phases of acute, persistent, and latent infection (3) (4) (5) . Because CMV replication is species restricted, readily tractable animal models for studying human CMV (HCMV) infection are unavailable, and mouse CMV (MCMV; a natural mouse pathogen) has provided invaluable insight into the mechanisms required for both innate and adaptive immune control of CMV infection.
Type I interferon (IFN-I) and natural killer (NK) cells are key components of innate defense against infections with most viruses, including MCMV (6) . High systemic IFN-I levels are detectable as early as 6 h after MCMV infection (7) , peaking at ϳ8 to 12 h (8) . A second wave of systemic and splenic IFN-I occurs at ϳ36 to 48 h. At 36 h, the majority of this IFN-I is produced by plasmacytoid dendritic cells (pDCs) in a Toll-like receptor (TLR)-and MyD88-dependent manner (9) (10) (11) (12) (13) (14) , and this level of production occurs almost simultaneously with completion of the first round of MCMV replication in the spleen (8) . Slightly later (ϳ44 to 48 h), the bulk of IFN-I is produced by conventional DCs (cDCs) in a MyD88-independent fashion. This composite, second wave of the innate response occurring at 36 to 48 h is critical for efficient NK cell activation and restriction of MCMV replication at days 2 to 3 of infection. MyD88-and TLR9-deficient (MyD88 Ϫ/Ϫ and TLR9 Ϫ/Ϫ ) mice exhibit severely reduced levels of systemic IFN-I, interleukin-12 (IL-12), and gamma interferon (IFN-␥) at 36 h and enhanced MCMV replication at 72 to 96 h (11, 12, (14) (15) (16) , due, at least in large part, to defective cytokine-mediated NK cell activation (10, (17) (18) (19) (20) (21) . IL-12 activates NK cells in a signal transducer and activation of transcription 4 (STAT4)-dependent manner, resulting in their production of IFN-␥ (10, (18) (19) (20) 22) . Commensurately, IFN-I induces the proliferation and cytotoxicity of NK cells during MCMV infection through the regulation of STAT1 and IL-15 (18, 19, 23) . Notably, MCMV infection actually promotes a loss of total splenic NK cells during the first 2 days, with a subsequent expansion/activation of Ly49H-positive (Ly49H ϩ ) NK cells in C57BL/6 (B6) mice occurring at time points after day 2 through recognition of the viral m157 protein (24) (25) (26) (27) (28) .
Previous work has shown that innate defenses regulated by lymphotoxin ␣␤ (LT␣␤)-LT␤ receptor (LT␤R) signaling are important for early control of MCMV (29) (30) (31) . The initial systemic and splenic IFN-I that peaks at ϳ8 to 12 h after MCMV infection is produced by splenic stromal cells that express LT␤R and requires B cells that express LT␣␤ (8, 32) . This innate defense mediated by LT␣␤-expressing B cells is not unique to stromal cells, as cross talk between B cells and LT␤R-expressing subcapsular sinus macrophages has recently been shown to regulate IFN-I production in the lymph node during vesicular stomatitis virus (VSV) infection (33, 34) . Recently, marginal-zone (MZ) stromal cells have been shown to be the first cells infected by MCMV in the spleen (35) , and they are also the initial source of splenic IFN-␤ (36) . Unlike pDC production of IFN-I, which occurs at 36 h, the initial production of IFN-I by the MZ stroma occurs independently of TLR signaling and requires the noncanonical NF-B pathway (8) .
This study assesses the role that IFN-I produced by the splenic MZ stroma plays in regulating innate defense against MCMV. Our results indicate that this first burst of innate cytokine emanating from reticular cells and requiring LT␣␤-mediated signals is criti-ences) and analyzed using FlowJo software (TreeStar). To delineate the role of IFN-IR on NK cells in IFN-␥ production at early times, splenocytes from IFN-IR Ϫ/Ϫ and WT mice were adoptively transferred into congenically marked (CD45.1 ϩ ) WT recipient mice. Splenocytes were isolated from donor mice, and red blood cells were lysed. Splenocytes were washed twice in sterile PBS. Approximately 30 million cells were transferred intravenously per recipient mouse in 100 l PBS. At ϳ30 h after cell transfer, mice were infected with MCMV, and 12 h later, donor and recipient NK cells were analyzed for IFN-␥ production.
In situ quantification of MCMV-infected cells in splenic marginal zones. In order to quantify the number of MCMV-infected cells within marginal zones in the spleen, mice were inoculated with 5 ϫ 10 5 PFU of GFP-expressing MCMV (38) 12 h before the analysis. In addition, 30 min before harvesting the spleens, mice were injected intravenously with 10 g of PE-labeled antibody recognizing CD169 (Biolegend) to stain marginalzone macrophages. Collected spleens were cut longitudinally in half, immobilized in a dish with the inner side facing up using a tissue glue (Vetbond), and immersed in PBS. Explants were immediately imaged with a water-dipping objective (magnification, ϫ20; numerical aperture, 0.95; Olympus) on a Leica SP5 MP microscope using two-photon excitation by a femtosecond-pulsed Ti:Sapphire infrared laser (Chameleon Ultra II; Coherent) tuned to 940 nm. Emitted light was detected in a 4-channel nondescanned detector photomultiplier tube detection unit equipped with 495-nm, 560-nm, and 620-nm dichroic long-pass mirrors and 525/ 50, 610/75, and 624/40 band-pass filters, so second harmonic generation (Ͻ495 nm), GFP (500 to 550 nm), PE (572.5 to 620 nm), and autofluorescence (620 to 644 nm) signals, respectively, could be recorded.
Follicles with surrounding rings of CD169 ϩ cells were identified, and typically, 4 xyz stacks with a 3-m z step were acquired to reconstruct 200-to 300-m-deep volumes within one follicle. The stacks of images were processed using Fiji/ImageJ software. To reduce the autofluorescent background, which masked the GFP signal, channel arithmetic was performed and the autofluorescence channel (620 to 644 nm) was subtracted from the GFP channel, followed by median filtering (1-pixel radius). Next, two-dimensional maximum-intensity projections were obtained from filtered three-dimensional stacks and stitched with the MosaicJ plug-in to produce one image showing a full marginal-zone ring. To further reduce the remaining background, a rolling-ball background subtraction (sliding paraboloid) was performed with a radius of 20 pixels. Finally, GFP-positive (GFP ϩ ) cells within the marginal zones were quantified in Slidebook (version 5.5) software (3i, Inc.), after thresholding of the GFP channel.
Statistical analysis. Differences between groups were evaluated for statistical significance by the two-tailed unpaired Student t test. Results are expressed as the mean Ϯ standard error of the mean. P values of Ͻ0.05 were considered significant.
RESULTS

IFN
-I produced from infected marginal-zone stromal cells is essential for MCMV defense. Our previous work demonstrated that the first cells infected by MCMV in the spleen are stromal cells (ϳ4 to 8 h after i.p. infection), resulting in their production of IFN-I in an LT␣␤-LT␤R-dependent manner (8) . These stromal cells localize in the splenic MZ and express the cell surface markers ERTR-7 and MADCAM-1 (35, 36) . We hypothesized that this earliest wave of innate cytokine production may be a critical factor in setting the stage for MCMV immune defense, prior to DCderived innate cytokine production at ϳ36 to 48 h of infection. To test this, the earliest time point that MCMV production in the spleen could reliably be detected was determined. WT B6 mice were infected, and the numbers of viral PFU were determined in the spleen 28 and 32 h later. At 28 h, less than half the mice had detectable numbers of MCMV PFU, whereas by 32 h all mice displayed measurable numbers of PFU at similar levels (Fig. 1A) . Additionally, MCMV PFU production was detectable in the liver of most mice by 28 h, albeit the level was significantly lower than that seen at 32 h (Fig. 1B) . Notably, these results are consistent with our previous quantitative PCR (qPCR) data suggesting that MCMV spread in the spleen and liver starts with virus produced ϳ30 to 36 h after i.p. infection (8) .
To test whether this first wave of IFN-I produced from the MZ stroma functions to restrict MCMV production, PFU levels were determined in spleens of WT and IFN-IR Ϫ/Ϫ mice at 32 h. Strikingly, MCMV replication was dramatically higher in IFN-IR Ϫ/Ϫ mice at this time (100-to 1,000-fold; Fig. 2A ), indicating a critical importance for stromal cell-coordinated innate defense at the very earliest times. IFN-I mRNA levels peak at a similar time in both the liver and spleen during initial MCMV infection (ϳ8 h) but show a differential dependence upon LT␣␤ signaling (8) . Nevertheless, an increase in MCMV production at 32 h was also observed in the liver of IFN-IR Ϫ/Ϫ mice, albeit it was not as dramatic as that in the spleen (ϳ10-fold; Fig. 2A ). Taken together, these results demonstrate that the initial wave of IFN-I is required to restrict MCMV production from the first infected cells in both the spleen and liver. Confirming the results seen in IFN-IR Ϫ/Ϫ mice, treatment of WT mice with an anti-IFN-IR-blocking antibody (MAR-1) (39) enhanced MCMV production at 32 h in the spleen (Fig. 2B ), although the absolute increase was less than that seen in IFN-IR Ϫ/Ϫ mice (ϳ10-fold). Taken together, both approaches highlight the critical importance of IFN-I signaling in promoting initial MCMV defenses.
IFN-I inhibits MCMV gene expression in MZ stromal cells. Higher levels of MCMV production from initially infected splenic MZ stromal cells at 32 h in IFN-IR
Ϫ/Ϫ mice might result from enhanced viral replication per infected cell. However, it may also be due to an increase in the number of initially infected stromal cells, a plausible hypothesis given that IFN-I can prime the pump to reduce the sensitivity of cells to initial infection (40, 41) . To address this issue, MCMV immediate early (IE) gene expression was assessed in the spleens of WT and IFN-IR Ϫ/Ϫ mice by qPCR at 8 h, as ie1 and ie3 are detectable at this early time and their levels are linearly proportional to the viral inoculation dose (8) . At 8 h, ie1 and ie3 transcripts were detected at similar levels in both B6 and IFN-IR Ϫ/Ϫ mice (50 to 200 times over the background level), strongly suggesting that similar numbers of MZ stromal cells are initially infected in these two strains (Fig. 3A) . Additionally, expression of gB (an early/late gene) and the late genes m74, m156, and m165 (42, 43) was assessed at 24 and 32 h, times nearing or at the completion of the first round of MCMV replication in the MZ stroma. At both these times, ϳ100-fold higher levels of mRNA expression of all MCMV genes were observed in IFN-IR Ϫ/Ϫ mice than WT mice (Fig. 3B) . The enhanced mRNA expression observed in IFN-IR Ϫ/Ϫ mice closely correlated with the increased viral production observed at 32 h. The qPCR analysis of immediate early genes indicates that similar numbers of cells are initially infected in WT and IFN-IR Ϫ/Ϫ mice. To conclusively determine if this is the case, WT and IFN-R Ϫ/Ϫ mice were infected with GFPexpressing MCMV (38) and GFP ϩ cells were quantified in situ by two-photon microscopy at 12 h after infection. Similar numbers of GFP ϩ cells were observed in the marginal zone of both WT and IFN-IR Ϫ/Ϫ mice. Marginal zones were identified by staining of MZ macrophages using anti-CD169 antibody, and GFP ϩ cells were quantified in five individual MZ regions in both types of mice (Fig. 3C) . These results, along with those of qPCR analysis, strongly support the conclusion that similar numbers of MZ stromal cells are initially infected in IFN-IR Ϫ/Ϫ mice and these mice lack a key antiviral effector function(s) that results in an inability to control virus production in the initially infected population of MZ stromal cells.
NK cells help to restrict MCMV production from the initially infected MZ stroma. Activation of NK cells by IFN-I and other proinflammatory cytokines (e.g., IL-12) is an important component of MCMV defenses at days 2 to 4 in the spleen of B6 mice (10, (18) (19) (20) (44) (45) (46) . CD69 upregulation on the surface of splenocytes during the initial stages of MCMV infection is absolutely dependent upon IFN-I signaling (data not shown). Assessment of splenic NK cells at 12 h after infection indicated that they are subject to activation by IFN-I at this early time, as CD69 expression was robustly induced (data not shown). To ascertain if initial IFN-I acts directly on infected cells to inhibit MCMV production or indirectly through the activation of NK cells, mice were antibody depleted of NK cells 24 h prior to infection. NK cell depletion was verified to be virtually complete in spleen and blood at the time of infection (data not shown), and MCMV production was measured 32 h later ( Fig. 4A and B) . Mice depleted of NK cells showed significantly more PFU in the spleen at 32 h than mice not depleted of NK cells, revealing that NK cells do contribute to controlling the first burst of virus production from the MZ stroma. However, compared to IFN-IR Ϫ/Ϫ mice, NK cell-depleted WT mice still showed markedly better control of MCMV production at 32 h (PFU levels were ϳ1 to 10% of those in IFN-IR Ϫ/Ϫ mice), indicating that IFN-I-dependent control is only partially mediated by NK cells, with the caveat that NK cell depletion was only ϳ98% effective in our experiments (Fig. 4A) . Notably, NK cell control of MCMV in the first infected cells is organ specific, as no difference in the number of PFU was seen in the livers of NK cell-depleted mice at 32 h (Fig. 4B) .
MZ stroma-produced IFN-I activates NK cells to produce IFN-␥. The robust IFN-␥ production by NK cells observed at 36 h Ϫ/Ϫ mice were harvested at 12 h postinfection, and GFP ϩ MCMV-infected cells were quantified in the MZ. A representative white pulp from each mouse is shown (green, GFP; blue, CD169). GFP ϩ cells were quantified in five white pulp MZ regions, and average numbers are graphed. Results are representative of 4 mice per group from a minimum of three independent experiments (*, P Ͻ 0.05; **, P Ͻ 0.005; ***, P Ͻ 0.0005; ns, not significant).
after MCMV infection of B6 mice occurs in response to pDCderived IL-12 and is dependent upon cell-intrinsic STAT4 signaling (10, 18) . As NK cell activation during the first 12 h of infection is strictly dependent upon IFN-IR (as assessed by NK cell induction of CD69), this raised the question of whether NK cells also produce effector cytokines at this very early time. To test this, WT B6 mice were infected with MCMV, and IFN-␥ production by splenic NK cells was assessed at 12, 24, and 36 h postinfection ( Fig.  5A and B) . As seen previously, ϳ40% of NK cells produced IFN-␥ at 36 h (47) . No IFN-␥ production by NK cells was observed at 24 h, also consistent with previous studies (22) . Interestingly however, ϳ9% of NK cells were found to produce IFN-␥ at 12 h, a time point paralleling the peak of IFN-I production by MZ stromal cells. IFN-␥ production by splenic NK cells at 36 h is dependent upon IL-12 (19, 20) , and therefore, IL-12p70 levels in the serum were measured at 12, 24, and 36 h. Notably, no IL-12p70 was detected at 12 and 24 h, but high levels were observed at 36 h (Fig.  5C ). Similar results were obtained when IL-12p70 was measured in spleen homogenates (data not shown). Recently, IFN-I has been shown to induce IFN-␥ production by NK cells during lymphocytic choriomeningitis virus (LCMV) infection (48) . As our results suggested that IFN-␥ production by NK cells at 12 h after MCMV infection was independent of IL-12, the potential role of IFN-I signaling was assessed. IFN-IR Ϫ/Ϫ mice were infected with MCMV, and IFN-␥ production by NK cells was compared to that of WT mice at 12, 24, and 36 h. Notably, no NK cells produced IFN-␥ at 12 h in IFN-IR Ϫ/Ϫ mice, whereas at 36 h, markedly higher numbers (ϳ60 to 70%) made IFN-␥ (Fig. 5A and B) . In addition, no IL-12p70 was detected in the serum of IFN-IR Ϫ/Ϫ mice at 12 or 24 h, but greatly increased levels were seen at 36 h (Fig. 5C ). To demonstrate that the regulation of NK cell IFN-␥ at an early time is mediated by IFN-IR signaling, IFN-IR Ϫ/Ϫ splenocytes were adoptively transferred into congenically marked (CD45.1 ϩ ) WT mice prior to infection with MCMV. At 12 h after infection, IFN-␥ production was observed in recipient-derived WT NK cells but not in donor-derived IFN-IR Ϫ/Ϫ NK cells in the same mouse (Fig. 5D) . A similar experiment was performed where WT splenocytes were adoptively transferred in CD45.1 ϩ WT mice prior to MCMV infection. Here, equivalent IFN-␥ production was observed in both donor and recipient WT NK cells (data not shown). Together these results suggest that a component of the NK cell-mediated control of initial MCMV replication in infected MZ stromal cells is likely due to IFN-I-dependent regulation of effector cytokine production.
Role of select NK cell subsets and pattern recognition receptors (PRRs) in initial MCMV control. A subset of Ly49H
ϩ NK cells (ϳ50% in naive B6 mouse spleens) expands and exerts robust control of MCMV replication in B6 mice as a result of binding the viral m157 protein (24) (25) (26) 49) . However, the contribution of these cells in controlling the first burst of MCMV production from the MZ stroma has not been directly assessed previously. To address this, WT B6 mice were infected with WT MCMV or a mutant lacking expression of m157, and virus production was measured in the spleen at 32 h (Fig. 6A ). No differences in the replication of the MCMV⌬m157 mutant compared to that of WT virus were observed, indicating that early NK cell effector control of MCMV is independent of m157-Ly49H interactions.
In addition, the contribution of selected pattern recognition receptors in restricting initial MCMV production was also tested. Mice lacking all TLR signaling (deficient for both MyD88 and TRIF), Cardif/mitochondrial antiviral signaling protein (MAVS)-mediated recognition, or Nalp3-dependent inflammasome responses were infected with MCMV, and splenic replication levels were measured at 32 h. MyD88 Ϫ/Ϫ /TRIF lps2/lps2 mice showed no differences in MCMV levels at 32 h compared to WT mice (Fig.  6B) , as was expected on the basis of our previous observations that TLR signaling does not regulate the initial IFN-I response from infected splenic stromal cells (8) . In addition, Cardif Ϫ/Ϫ and Nalp3 Ϫ/Ϫ mice also showed no increases in splenic MCMV replication at 32 h (Fig. 6B) , suggesting either that these innate defense pathways are not operable during MCMV infection or that the virus effectively neutralizes them in infected MZ stromal cells.
Initial innate immunity sets the baseline for MCMV replication and restricts productive MCMV spread. The levels of MCMV produced from MZ stromal cells by 32 h struck us as being surprisingly high (10 3 to 10 4 PFU/g), as in our experience, the number of viral PFU does not reach much higher levels at later times of the acute phase of infection in B6 mice. To address this directly, WT B6 mice were infected with MCMV and virus production was measured at 32, 48, 72, 96, and 120 h after infection (Fig. 7A) . Notably, MCMV replication levels at 32 h represented the peak of MCMV production in the spleen over the entire course of the acute phase of infection. In contrast, this was not true for IFN-IR Ϫ/Ϫ mice, as not only was MCMV production 100-to 1,000-fold higher at 32 h in IFN-IR Ϫ/Ϫ mice than WT mice, but also PFU levels were significantly enhanced at both 48 and 96 h compared to those at the 32-h time point (Fig. 7B) .
These results strongly support a model where initial IFN-I production from MZ stromal cells limits MCMV replication in the same cells, setting a baseline for MCMV production during the entire course of acute infection. Additionally, the absence of increased numbers of PFU at later times suggested that the early IFN-I and NK cell responses may restrict productive MCMV spread to neighboring cells in WT mice, whereas IFN-IR Ϫ/Ϫ mice may lack this tight control. To test this directly, MCMV gene expression in the spleens of B6 and IFN-IR Ϫ/Ϫ mice was assessed by qPCR at 32 and 48 h after infection (Fig. 7C) . We hypothesized that at 32 h infectious MCMV particles, measurable by plaque assay and produced from the first infected MZ stromal cells, should theoretically be capable of infecting neighboring cells, with a commensurate increase in IE and/or early transcripts being detectable. If productive replication then occurs in this second pool of infected cells, by 48 h an increase in early mRNAs accompanied by measurable late gene expression should be detectable. In WT mice, ie1 levels were found to increase by ϳ5-fold at between 32 and 48 h, suggesting that a second pool of cells may initially be infected in the spleens of immunocompetent mice. However, no increases in mRNAs for ie3, early, or late genes (ie3, gB, m74, m156, and m165) were observed at between 32 and 48 h. In contrast, transcripts for all classes of MCMV genes increased ϳ10-fold in the spleens of IFN-IR Ϫ/Ϫ mice at between 32 and 48 h, consistent with a model where a second round of replication (i.e., spread) is initiated, maintained, and progresses in the absence of IFN-I signaling.
DISCUSSION
The IFN-I response is critical for defense against viral pathogens. MCMV infection results in a biphasic IFN-I response, with the initial wave peaking at ϳ8 h and being produced by splenic MZ stromal cells in a B-cell-and lymphotoxin-dependent manner (8) and a second sustained wave of IFN-I produced by DC subsets occurring at 36 to 48 h (6, 9, 10). Importantly, at infectious doses of MCMV commonly used by most laboratories (ϳ10 4 to 10 5 PFU), the magnitude of the IFN-I response at 8 h is roughly equivalent to, if not greater than, that of the DC-produced wave in B6 mice (8) . Consequently, we examined the relative importance of the initial stroma-derived IFN-I in the control of MCMV, and our results indicate that it is essential to restrict the initial burst of MCMV from infected MZ stromal cells and also establish the upper limit for MCMV replication over the entire course of acute infection. NK cells were also shown to be critical for the initial control of MCMV in the spleen, but not the liver, with their activation being dependent upon the first wave of IFN-I production. Taken together, our results indicate that MZ stromal cells are crucial orchestrators of the earliest phase of innate defense against MCMV infection through their production of IFN-I. A large body of work from studies performed in B6 mice unequivocally demonstrates an important role for innate defenses coordinated by pDCs and cDCs in restricting MCMV production at time points after 48 h of infection. Mice deficient in this second wave of DC-derived innate cytokines are severely compromised in controlling MCMV replication in the spleen and liver at day 3 of infection and beyond, highlighted by studies performed in mice lacking MyD88 and nucleic acid-sensing TLRs (e.g., TLR3/7/9) (6, 9-16). However, the relationship between individual DC subsets, the innate cytokines that they produce, and the mechanisms of innate defense that they direct to ultimately control MCMV replication is quite complicated. pDCs are clearly the major source of splenic and systemic IFN-I at 36 h of infection, a time point which coincides very closely with the first burst of MCMV production from the initially infected MZ stromal cells. However, although depletion of pDCs with antibodies results in a marked reduction of IFN-I at 36 h, MCMV replication is essentially unaffected (11, 12) . A more recent study utilizing BDCA-2 diphtheria toxin receptor-transgenic mice to specifically deplete pDCs showed very similar results (13) , with a marked reduction in the IFN-I response at 36 h but only a modest increase in MCMV splenic production at day 3 when mice were infected with 5 ϫ 10 4 PFU (ϳ3-to 4-fold increase) and no difference when mice were infected with just a 2-fold higher dose of virus. These data strongly suggest that although pDCs are the major source of IFN-I at 36 h, compensatory mechanisms exist to control MCMV replication at time points after 48 h of infection (e.g., those coordinated by cDCs). In contrast, the 100-to 1,000-fold increase in MCMV replication observed at 32 h in the spleens of IFN-IR Ϫ/Ϫ mice identifies the LT␣␤-dependent, TLR-independent, stroma-produced IFN-I as playing a dominant and nonredundant role in controlling MCMV replication at the earliest stages of infection.
Although pDCs are not required for efficient control of MCMV replication in the spleen, the second wave of innate defenses derived from TLR-dependent mechanisms is critical for controlling MCMV at later times of infection (e.g., day 3 and later). A number of cytoplasmic PRRs sense viral infection and regulate innate cytokine production (reviewed in references 50 to 53). The initial IFN-I produced by splenic MZ stromal cells is linearly proportional in magnitude to the virus inoculum, implying that MCMV may be directly sensed by a PRR in these cells. Our results suggest that TLR-, Cardif-, and Nalp3 inflammasome-de- Ϫ/Ϫ /TRIF lps2/lps2 , Nalp3 Ϫ/Ϫ , and Cardif Ϫ/Ϫ mice were infected with MCMV, and splenic PFU production was measured 32 h later. Results are representative of a minimum of 4 mice per group from at least two independent experiments. ns, not significant.
FIG 7 Initial IFN-I restricts productive MCMV replication to the first infected cells. B6 (A) and IFN-IR
Ϫ/Ϫ (B) mice were infected with MCMV, and virus production was measured in the spleen at the specified times postinfection. (C) Spleens from MCMV-infected WT and IFN-IR Ϫ/Ϫ mice were analyzed for ie1, ie3, gB, m74, m156, and m165 mRNA levels by qPCR at 32 and 48 h. Results are representative of 4 mice per group from a minimum of three independent experiments (*, P Ͻ 0.05; **, P Ͻ 0.005; ***, P Ͻ 0.0005; ns, not significant). pendent pathways do not regulate the initial IFN-I response to MCMV infection in MZ stromal cells. Recent studies have identified IFI16, a PHYIN family member, to be the cytoplasmic doublestranded DNA sensor that can sense viral DNA sequences and result in IFN-␤ induction after recognition of transfected DNA sequences from herpes simplex virus 1 and vaccinia virus (54) . Similarly, the cytoplasmic DNA sensor ZBP-1 is required for interferon regulatory transcription factor 3 activation and IFN-␤ induction by human fibroblasts infected with HCMV (55) . Both these studies demonstrate the requirement for the adaptor molecule STING for IFN-␤ production after viral DNA recognition. Although the DNA-dependent activator of interferon regulatory factor has been shown to promote MCMV-induced programmed necrosis, a process inhibited by the viral M45 protein, there is no evidence to date that this DNA sensor regulates the IFN-I response (56) .
This study revealed a role for NK cells in restricting at 32 h MCMV production from the initially infected MZ stromal cells, whereas NK cells had no impact on viral replication in the liver at this early time. To our knowledge, this is the earliest time point where NK cells have been shown to contribute to innate defenses against MCMV. NK cell activation is dependent on IFN-I at as early as 12 h postinfection, as assessed by the complete lack of CD69 upregulation on the NK cell surface at this time in IFN-IR Ϫ/Ϫ mice (data not shown). One of the antiviral effector mechanisms believed to be employed by NK cells at 36 to 48 h is mediated by their robust production of IFN-␥, which is largely dependent upon DC-derived IL-12 (10) (11) (12) 14) . Here we show that splenic NK cells are capable of producing IFN-␥ much earlier during infection and exhibit a biphasic expression pattern for this effector cytokine that parallels the two waves of innate cytokine production derived from stromal cells and DCs (e.g., at 12 and 36 h). Our results prove that the NK cell-produced IFN-␥ production at 12 h is absolutely dependent on IFN-I signaling and occurs in the absence of detectable splenic or systemic IL-12 expression, a finding clearly differentiated from the findings of studies showing a critical role for IL-12 in the induction of IFN-␥ by NK cells at the 36-h time point. These results are reminiscent of what has recently been reported for LCMV infection, where peritoneal cavity NK cells produce IFN-␥ early, 30 h after infection, in an IFN-I-and STAT4-dependent manner (48) . Marked enhancement of IL-12 and NK cell-produced IFN-␥ is observed at 36 h in IFN-IR Ϫ/Ϫ mice, and this may be due to the absence of negative regulation by IFN-I, as suggested by others (10, 13, 57) , but it may also simply result from the dramatically higher viral loads present in these mice at 32 h. Regardless, it is intriguing that this enhanced NK cell activation does not curtail the markedly higher MCMV replication seen in these mice as infection progresses. Perhaps IFN-␥ is not the critical mechanism for NK cell-mediated control of acute MCMV infection in the spleen (45, 46) . Alternatively, once a high baseline of MCMV production is established in the initially infected MZ stromal cells, immune-modulatory strategies employed by the virus may restrict IFN-␥ antiviral activity (58) .
Our results place MZ stromal cells at a critical apex in the coordination of innate defense against MCMV infection in B6 mice, as they are both the first cells infected and the first to produce IFN-I in the spleen. Interestingly, BALB/c mice produce ϳ100-fold higher levels of MCMV at 32 h than B6 mice (data not shown). Consistent with this, we have previously shown that MCMV-infected BALB/c mice produce ϳ100-fold less IFN-I in the spleen at 8 h of infection than do B6 mice (8) . We would propose that the dramatically enhanced MCMV production at 32 h in the spleens of BALB/c mice is due, at least in part, to their inability to mount a robust IFN-I response at the earliest times of infection. Recent results suggest that a key downstream effector pathway regulated by IFN-I signaling that mediates its antiviral effects is linked to sterol biosynthesis (59) , and whether the relative contribution of this pathway may also vary depending upon the mouse strain is an open question.
One of the more striking results of this study is that MCMV production in the spleen remains remarkably constant over the first 4 to 5 days of infection, never peaking above the levels detected at 32 h. This raises the possibility that MZ stromal cells are the only cells that are productively infected in the spleen and that the virus employs immune-modulatory strategies to avoid clearance by the innate immune system until sufficient adaptive immunity develops at days 5 to 7 of infection, which only then results in the ultimate control of replication. The relatively constant levels of MCMV PFU produced over the first 5 days of infection in the spleen correlate well with analyses of MCMV gene expression, where no increases in mRNA levels were seen for IE or late gene transcripts at time points after 24 h, except for ie1, which may have a low level of abortive spread that is initiated but does not progress to productive replication. Our results indicate that both IFN-I and NK cells play a key role in setting this baseline of innate control. The importance of NK cells in this regard is also supported by work showing that WT MCMV is controlled in the spleens of SCID mice for several weeks, with replication levels remaining relatively constant and similar to those that we have observed in WT mice, but eventually, mutations in m157 that result in viral escape from NK cell control and death of the mice due to the absence of an adaptive response occur (60) Similarly, passage of MCMV through CMV1 r /Ly49H ϩ mice results in generation of m157 mutant MCMV that either lacks expression of m157 or does not activate NK cells via Ly49H engagement (61) .
This begs the question of whether it benefits the virus or the host for low-level replication of MCMV to be maintained in MZ stromal cells. Interestingly, a similar phenomenon has been described for VSV infection in the spleen, where viral replication is maintained in the initially infected marginal-sinus macrophages, which results in the better priming of adaptive immune responses and prevention of viral dissemination and disease (62) . Could it be that MZ stromal cells perform a similar function in the case of MCMV infection? In this regard, MCMV replication persists for longer times in the salivary glands of B6 mice than those of BALB/c mice and results from the generation of a weaker CD4T cell response in this strain (63) . Since B6 mice exhibit better control of MCMV in the MZ stroma at early times in the spleen, perhaps this contributes to the priming of a weaker CD4 T cell response that is unable to effectively restrict MCMV persistence in the salivary gland. In addition, when acute replication is eventually brought under complete control in the spleen by the adaptive response, MCMV likely establishes latency in the same MZ stromal cells (64, 65) , raising the possibility that the robustness of the innate response may regulate both the persistent and latent phases of infection. Taken together, it is clear that lymphoid-tissue stromal cells are critical coordinators of innate defense against MCMV during the initial hours of infection that set the stage for the lifelong relationship between this virus and its host.
